Treatment Options for High Cardiometabolic Risk Patients with Atherosclerosis
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5529Keywords:
High Cardiometabolic Risk Patients, Atherosclerosis, Treatment optionsAbstract
In 2020, coronary artery disease (CAD) affected over 20 million people and resulted in 382,820 deaths in the United States. Heart disease such as CAD and its precursor atherosclerosis have severe consequences such as limiting the amount of blood flow and reducing the flow of vital elements like oxygen to vital tissues and organs like the heart. Elderly adults, obese patients, patients with diabetes, and those with a genetic predisposition of increased Low-Density Lipids (LDLs), are at higher risk of developing atherosclerosis. This paper examines treatment options for atherosclerosis in people with high cardiometabolic risk and discusses their efficacy as well as their associated risks and benefits. First-line therapy includes medication such as statins, ACE Inhibitors, or diuretics along with appropriate lifestyle adjustments. If unsuccessful, second-line interventions offer increased risk reduction in patients with established coronary vascular disease and reduce the probability of recurrence of an acute cardiac event. This calls for the use of medication with higher risks such as beta blockers and anti-thrombotics and even surgical procedures such as bypass and angioplasties. Regardless of the patient’s condition, the first recommendation for preventing and managing atherosclerosis is lifestyle adjustment. Medications offer benefits but with varying levels of side effects. Thus, it is important to look at the specific conditions of each patient to find the most suitable medication. This paper looked at the existing magnitude of treatments for atherosclerosis and summarised which ones are best for patients with different conditions that put them at high risk for developing atherosclerosis.
Downloads
References or Bibliography
Works Cited:
Akdim, Fatima, et al. “Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia.” European Heart Journal, 18 May 2011, https://academic.oup.com/eurheartj/article/32/21/2650/438837?login=false. Accessed 16 May 2023.
Amarenco, Pierre, et al. “Statins in Stroke Prevention and Carotid Atherosclerosis.” AHA Journals, 28 October 2004, https://www.ahajournals.org/doi/full/10.1161/01.str.0000147965.52712.fa. Accessed 16 May 2023.
“Antiplatelet Drugs: Types, Uses & Side Effects.” Cleveland Clinic, 5 May 2022, https://my.clevelandclinic.org/health/drugs/22955-antiplatelet-drugs. Accessed 16 May 2023.
Aronson, Doron, and Elliot J. Rayfield. “How hyperglycemia promotes atherosclerosis: molecular mechanisms - Cardiovascular Diabetology.” Cardiovascular Diabetology, 8 April 2002,
https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-1-1. Accessed 10 April 2023.
“ASCVD Risk Estimator.” ASCVD Risk Estimator, https://tools.acc.org/ldl/ascvd_risk_estimator/index.html#!/calculate/estimator/. Accessed 22 May 2023.
“Atherosclerosis.” Johns Hopkins Medicine, https://www.hopkinsmedicine.org/health/conditions-and-diseases/atherosclerosis. Accessed 9 April 2023.
Barnes, Geoffrey D. “Antithrombotic Therapy in the Elderly: ESC Expert Position Paper.” American College of Cardiology, 27 July 2015, https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2015/07/27/15/59/antithrombotic-therapy-in-the-elderly-expert-position-paper. Accessed 10 April 2023.
“Beta-blockers: Types, Uses and Side Effects.” Cleveland Clinic, 18 January 2022, https://my.clevelandclinic.org/health/treatments/22318-beta-blockers. Accessed 16 May 2023.
Bittencourt, Marcio Sommer, and Rodrigo Julio Cerci. “Statin effects on atherosclerotic plaques: regression or healing? - BMC Medicine.” BMC Medicine, 8 October 2015, https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0499-9. Accessed 10 April 2023.
Capodanno, Davide, and Dominick J. Angiolillo. “Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.” AHA Journals, 30 November 2020, https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.045465. Accessed 10 April 2023.
“Catheter-directed Thrombolysis.” RadiologyInfo.org, https://www.radiologyinfo.org/en/info/thrombo. Accessed 16 May 2023.
Chyu, Kuang-Yuh, and Prediman K. Shah. “HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis.” Frontiers, 1 September 2015, https://www.frontiersin.org/articles/10.3389/fphar.2015.00187/full. Accessed 31 May 2023.
DeBakey, ME. “Surgical treatment of atherosclerotic heart disease.” PubMed, 2 May 1989, https://pubmed.ncbi.nlm.nih.gov/2784933/. Accessed 10 April 2023.
DTN Staff. “Diabetes - Can Diabetics Take Diuretics.” DiabetesTalk.Net, 3 April 2018, https://diabetestalk.net/diabetes/can-diabetics-take-diuretics. Accessed 10 April 2023.
Goldman, Rena, and Payal Kohli. “Atherosclerosis: Symptoms, Causes, Diagnosis, and Treatment.” Healthline, 27 February 2020, https://www.healthline.com/health/atherosclerosis. Accessed 9 April 2023.
Henning, Robert J. “Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity.” NCBI, 15 August 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449192/. Accessed 11 April 2023.
HIV.gov. “First-Line Therapy | NIH.” Clinical Info HIV.GOV, https://clinicalinfo.hiv.gov/en/glossary/first-line-therapy. Accessed 31 May 2023.
Hoffman, Matthew. “Treatments for Advanced Atherosclerosis: Coronary Bypass or Angiography and Stent.” WebMD, 5 November 2022, https://www.webmd.com/cholesterol-management/treatments-for-advanced-atherosclerosis. Accessed 10 April 2023.
Institute for Work & Health. “Primary, secondary and tertiary prevention.” Institute for Work & Health, April 2015, https://www.iwh.on.ca/what-researchers-mean-by/primary-secondary-and-tertiary-prevention. Accessed 31 May 2023.
Kohli, Payal. “Angioplasty: Types, procedure, risks, and recovery.” Medical News Today, 28 November 2019, https://www.medicalnewstoday.com/articles/327154#procedure. Accessed 16 May 2023.
Kumbhani, Dharam J. “Dual Antiplatelet Therapy - DAPT.” American College of Cardiology, 16 February 2018, https://www.acc.org/latest-in-cardiology/clinical-trials/2014/11/18/16/27/dapt-study. Accessed 31 May 2023.
LaMorte, Wayne W. “Pathogenesis of Atherosclerosis.” SPH, 8 October 2016, https://sphweb.bumc.bu.edu/otlt/mph-modules/ph/ph709_heart/ph709_heart3.html. Accessed 9 April 2023.
LeBlanc, Erin S., et al. “Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.” JAMA, 18 September 2018, https://jamanetwork.com/journals/jama/article-abstract/2702877. Accessed 22 May 2023.
“Living Healthy with Diabetes.” American Heart Association, 6 May 2021, https://www.heart.org/en/health-topics/diabetes/prevention--treatment-of-diabetes/living-healthy-with-diabetes. Accessed 10 April 2023.
“Managing Hypertension in the Elderly: A Common Chronic Disease with Increasing Age.” American Health and Drug Benefits, vol. 5, no. 3, 2012. American Health and Drug Benefits, https://www.ahdbonline.com/articles/981-feature-981. Accessed 11 April 2023.
Mayo Clinic. “Angiotensin-converting enzyme (ACE) inhibitors.” Mayo Clinic, 8 September 2021, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480. Accessed 31 May 2023.
Mayo Clinic Staff. “Statin side effects: Weigh the benefits and risks.” Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statin-side-effects/art-20046013. Accessed 16 May 2023.
McGill, Janet B. “Reexamining Misconceptions About β-Blockers in Patients With Diabetes.” American Diabetes Association, 1 January 2009, https://diabetesjournals.org/clinical/article/27/1/36/1863/Reexamining-Misconceptions-About-Blockers-in. Accessed 10 April 2023.
Mcgowan, Mary P., et al. “Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.” AHA Journals, 16 December 2019, https://www.ahajournals.org/doi/10.1161/JAHA.119.013225. Accessed 16 May 2023.
Nied, Robert J., and Barry Franklin. “Promoting and Prescribing Exercise for the Elderly.” American Family Physician, 1 February 2002, https://www.aafp.org/pubs/afp/issues/2002/0201/p419.html. Accessed 10 April 2023.
O'Brien, Helen, and Rose Anne Kenny. “Syncope in the Elderly | ECR Journal.” European Cardiology Review, 12 June 2014, https://www.ecrjournal.com/articles/syncope-elderly. Accessed 25 May 2023.
Ogbru, Annette, and Jay W. Marks. “Types of Diuretics Medications: Uses, Side Effects, Interactions, List of Drugs.” RxList, 4 August 2022, https://www.rxlist.com/diuretics/drugs-condition.htm. Accessed 31 May 2023.
“PCSK9 Inhibitors: How They Manage Cholesterol and Side Effects.” Cleveland Clinic, 17 February 2022, https://my.clevelandclinic.org/health/drugs/22550-pcsk9-inhibitors. Accessed 16 May 2023.
Poirier, Oaul, and Martin A. Alpert. “Cardiovascular Evaluation and Management of Severely Obese Patients Undergoing Surgery.” AHA Journals, 15 June 2009, https://www.ahajournals.org/doi/full/10.1161/circulationaha.109.192575. Accessed 11 April 2023.
Poulson, Brittany. “Statins and Diabetes: Risks and Benefits.” Verywell Health, 15 February 2023, https://www.verywellhealth.com/statins-and-diabetes-5116077. Accessed 10 April 2023.
Puccini, M., and C. Rauch. “Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel. Cardiovasc Drugs Ther.” SpringerLink, 25 February 2022, https://link.springer.com/article/10.1007/s10557-022-07325-z?error=cookies_not_supported&code=0ca2e035-ec69-404f-ac39-eb24e0c25b3b. Accessed 11 April 2023.
Ratini, Melinda. “What a 5% Weight Loss Can Do for Your Health.” WebMD, 28 January 2023, https://www.webmd.com/diet/ss/slideshow-five-percent-weight-loss. Accessed 11 April 2023.
Rocha, Viviane Z., and Peter Libby. “Obesity, inflammation, and atherosclerosis.” Nature Reviews Cardiology, 28 April 2009, https://www.nature.com/articles/nrcardio.2009.55?error=cookies_not_supported&code=88cec101-06cc-4047-a5bf-7fa725dd6a9e. Accessed 11 April 2023.
Rosa, Roberta De, et al. “Antiplatelet therapy in very elderly and comorbid patients with acute coronary syndromes.” NCBI, 16 Feb 2019, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431602/. Accessed 16 May 2023.
Rubenfire, Melvyn. “CVD and Risk Management Standards in Diabetes Care.” American College of Cardiology, 18 May 2018, https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/05/18/10/54/cardiovascular-disease-and-risk-management-review. Accessed 10 April 2023.
Ryan, Angela. “Coronary artery disease: Causes, symptoms, and treatment.” Medical News Today, 8 February 2023, https://www.medicalnewstoday.com/articles/184130. Accessed 8 April 2023.
Sandfort, Veit, et al. “Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment.” NCBI, 13 July 2016, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015399/?report=reader. Accessed 22 May 2023.
Shah, Ahmed Ijaz, et al. “Comparison of coronary revascularization strategies in older adults presenting with acute coronary syndromes.” Journal of the American Geriatric Society, 16 April 2022, https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.17794. Accessed 16 May 2023.
Sharma, AM. “Use of beta-blockers in obesity hypertension: potential role of weight gain.” PubMed, 7 July 2008, https://pubmed.ncbi.nlm.nih.gov/12119998/. Accessed 11 April 2023.
Smith Jr., Sidney C., et al. “AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update.” AHA Journals, 3 November 2011, https://www.ahajournals.org/doi/10.1161/cir.0b013e318235eb4d. Accessed 16 May 2023.
“Statins and Cholesterol Medicine - HEART UK.” Heart UK, https://www.heartuk.org.uk/getting-treatment/statins. Accessed 16 May 2023.
Terada, Tasuku, et al. “Severe Obesity Is Associated With Increased Risk of Early Complications and Extended Length of Stay Following Coronary Artery Bypass Grafting Surgery.” JAHA, 1 June 2016, https://www.ahajournals.org/doi/10.1161/JAHA.116.003282. Accessed 22 May 2023.
Tyrrel, Daniel J., and Daniel R. Goldstein. “Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6.” NCBI, 11 September 2020, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484613/. Accessed 10 April 2023.
Williams, Nathan, and Christina Aungst. “Common Medication Side Effects in Elderly Patients.” GoodRx, 14 November 2022, https://www.goodrx.com/drugs/side-effects/common-drug-side-effects-older-adults. Accessed 10 April 2023.
Won, Ki Bum. “Evaluation of the impact of statin therapy on the obesity paradox in patients with acute myocardial infarction: A propensity score matching analysis from the Korea Acute Myocardial Infarction Registry.” NCBI, 1 September 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585471/. Accessed 11 April 2023.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Tanay Gour
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
